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Abstract  
Autonomous self-healing in carbon fibre reinforced polymer (CFRP) is demonstrated using 
epoxy resin filled microcapsules and a solid-state catalyst. Microcapsules filled with oligomeric 
epoxy resin (20–450 μm) and particles of Sc(OTf)3 are embedded in an interleave region of a 
unidirectional CFRP laminate and tested under mode I loading. Double cantilever beam (DCB) 
test specimens containing variable concentrations of microcapsules and catalyst were prepared, 
tested and compared to those healed by manual injection with corresponding healing resin 
formulation. The healing efficiency was evaluated by comparing the maximum peak load 
recorded on load–displacement curves for pristine and healed specimens. A 44% maximum 
recovery was observed for specimens containing 10 wt% of solid phase catalyst and 11 wt% of 
epoxy microcapsules. However, a significant (80%) decrease in initial strain energy release rate 
(GIC) was observed for specimens with the embedded healing chemistries. 
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1. Introduction 
 
Fibre reinforced polymer (FRP) composites are increasingly 
used in industries like aerospace, energy, automotive and in 
offshore structures due to their exceptional specific mechan-
ical properties compared to conventional materials [1]. In 
service, FRPs are susceptible to internal damage, including 
matrix cracking, fibres fracture, and delamination between 
plies. When undetected and unrepaired, these damages can 
be of significant detriment to performance, ultimately 
leading to premature failure. It can be addressed by 
embedding func-tionality capable of effecting autonomous 
repair, minimising often complicated and difficult damage 
detection strategies and manual maintenance [2–4]. 
 
Self-healing has already been widely studied in polymers 
and the fibre reinforced composites where autonomous repair 
has been achieved through a range of approaches [2–4] 
including embedding healing-agent-filled microcapsules [5– 
23], hollow fibres [24–26] or incorporating vascular networks 
capable of delivering various healing chemistries [27, 28]. 
These systems are considered as extrinsic, and mean that the 
healing chemistries are introduced externally into the crack 
planes. Another approach described in the literature includes 
intrinsic mechanisms, where the polymer is capable of healing 
without any external supply of healing agent [29–34]. The most 
developed approach to date sees microencapsulation of a 
healing monomer or oligomer within a polymeric shell, which 
are then embedded in a host material. Embedded 
 
 
 
   
 
microcapsules are ruptured by a propagating crack to release 
the healing agent, upon subsequent chemical reaction or 
physicochemical processes, new polymer bonds the fracture 
surfaces and restores the lost material properties [2–4].  
The first and most widely exploited microencapsulation 
system was proposed in 2001 by White et al [5]. In this 
approach, microencapsulated dicyclopentadiene (DCPD) was 
embedded in an epoxy polymer and polymerised following 
release in the presence of ruthenium Grubbs’ catalyst (ring 
opening metathesis polymerisation—ROMP). Despite high 
healing efficiencies [3], the high price of the ruthenium cat-alyst 
and its low stability in the presence of moisture, amine 
hardeners and oxygen, limited its commercialisation. Several 
modifications were proposed including protecting the Grubbs’ 
catalyst in wax or usage of alternative second generation, 
Hoveyda–Grubbs’ and Tungsten hexachloride as catalysts [6– 
8]. However, these barriers still limit DCPD/Grubbs’ system 
wider application in autonomous healing materials. To over-
come some of these issues and to provide a healing system that 
is chemically and mechanically compatible with a typical host 
epoxy matrix, less expensive diglycidyl ether of bisphenol A 
(DGEBA) was demonstrated as an alternative healing agent [7–
14]. Encapsulated DGEBA was combined with a variety of 
hardeners, including catalytic curing agents [9, 10, 20] and 
multifunctional amines [11–14]. In the most recent work, Coope 
et al [9] utilised scandium (III) triflate particles as a catalytic 
curing agent for an epoxy resin. A maximum of 80% of healing 
efficiency was achieved at ele-vated temperatures using tapered 
double cantilever beam (DCB) test specimens in a low 
temperature curing epoxy [9]. In other approaches, liquid phase 
and relatively toxic curing agents were utilised, such as boron 
trifluoride etherate hard-ener ((C2H5)2O · BF3) [10], 
epoxy/mercaptan [11, 12] and epoxy/amine chemistry [13, 14]. 
Within these works, two types of capsules were utilised to 
successfully separate the healing chemistries from the 
surrounding environment and the healing efficiency was often 
dependent on stoichiometric ratio and contact of both healing 
components.  
An alternative, single capsule approach to self-healing was 
demonstrated in the literature and utilised the inherent residual 
functionality of the host epoxy [2–4]. Healing is achieved via 
interaction of encapsulated solvent with residual functionality in 
the epoxy polymer. For instance, almost full recovery of mode I 
fracture toughness was demonstrated using solvent (ethyl 
phenylacetate) filled microcapsules [15, 16, 23]. Non-fully 
cured epoxy matrix is swollen by the solvent released from 
microcapsules and the residual func-tional groups initiate 
further crosslinking which re-bond fractured surfaces. The 
system was modified by use of shape memory alloys (SMA) to 
reduce the separation after fracture damage and to enhance the 
healing performance [17, 18]. However, the need for unreacted 
functional groups in under-cured epoxy limits the broader 
applications of this self-heal-ing system. Other, latent 
functionality was also proposed by Yin et al [19] where 
hardener dispersed in the matrix (CuBr2(2-methylimidazole)4) 
was available for a healing reaction, but required heating to 130 
°C to polymerise the released resin. Moreover, Xiao et al [20] 
studied a system 
 
using the (C2H5)2O · BF3 catalyst absorbed by short sisal 
fibres and protected by a polystyrene coating.  
In this work we demonstrate an autonomous self-healing 
unidirectional fibre reinforced composite structure of com-
mercially available epoxy resin/carbon fibre resin tape (SE 
70, Gurit, UK). Self-healing was achieved by embedding of 
epoxy resin filled microcapsules (20–450 μm) and solid state 
catalyst (Sc(OTf)3) in a damage region. The main aim of this 
work is optimisation and assessment of the selected system 
as a self-healing function within a high performance 
composite structure. Microencapsulated self-healing has 
already been demonstrated in epoxy polymers and their 
composites with woven fibres, however, application in 
unidirectional compo-sites is relatively unexplored. A 
maximum mode I DCB recovery of 42% is achieved for an 
autonomous system which is comparable to a manually 
initiated approach (52%). However, the high healing 
efficiency is associated with sig-nificant detrimental effect on 
the host polymer fracture properties. Nevertheless, it is 
demonstrated that micro-encapsulated self-healing can be 
achieved in a unidirectional composite cured at high 
temperature (100 °C) using a microcapsule—catalyst 
approach and that the healing func-tionality can be optimised 
to avoid any significant detrimental effects.  
In general, the selected epoxy resin–organic solvent system 
was encapsulated in a poly(urea-formaldehyde) shell using a 
standard processing technique described in the lit-erature [21]. 
Microcapsules and commercially sourced cata-lytic curing 
agent were embedded in an interleave region of a FRP laminate 
using standard hand lay-up techniques. After initial DCB tests 
to assess mode I strain energy release rate (GIC) recovery, the 
volume of embedded epoxy resin and catalyst loading were 
varied in order to assess the healing rate. Herein the effect of 
both components on the damage region is demonstrated and 
discussed in detail. Microcapsules con-taining DGEBA (75 
wt%) and high boiling point organic solvent, ethyl 
phenylacetate (25 wt%) have been documented in previous 
studies as an effective application of self-healing epoxides [9]. 
Scandium (III) triflate (Sc(OTf)3) was selected as a suitable 
initiator due to its stability and catalytic activity in the 
polymerisation of epoxy resins [9, 35–37]. Further-more, 
Sc(OTf)3 embedded in a carbon fibre reinforced poly-mer 
(CFRP) composite has been demonstrated as being capable of 
repeated healing via microvascular channels [37]. 
 
 
2. Materials and methods 
 
2.1. Materials 
 
Ethyl phenylacetate (EPA, C6H5CH2C(O)OC2H5), urea 
(NH2CONH2), poly(ethylene-alt-maleic anhydride) (EMA, Mw 
= 100 000–500 000, powder); resorcinol (C6H4-1,3-(OH)2), 
formaldehyde (37 wt% in H2O), ammonium chloride (NH4Cl) 
and scandium (III) triflate (Sc(OTf)3) were pur-chased from 
Sigma-Aldrich and used as received. Sodium hydroxide 
(NaOH) was purchased from Fisher Scientific. Commercial 
epoxy resin—EPON 828 was purchased from 
 
 
   
 
Table 1. Designation of all tested DCB specimens and composition of interleaf resin present in the damage region.   
Specimen type Healing mechanism Microcapsules size Epoxy microcapsules (wt%)
a 
Catalyst load (wt%)
a 
     
Control 1 Manual — — — 
Control 2 — — — — 
Autonomous  20–450 26 2.5 
5.5 wt_2.5 wt%   5.5 2.5 
11 wt_2.5 wt%   11 2.5 
26 wt_2.5 wt%   26 2.5 
11 wt_0.0 wt% Autonomous 250–450 11 0 
11 wt_1.0 wt%   11 1.0 
11 wt_5.0 wt%   11 5.0 
11 wt_10 wt%   11 10   
a Microcapsules and catalyst weight loading calculated relatively to SA 70 epoxy resin used as the filler. 
 
PolySciences, Inc. Carbon fibre/epoxy resin tape (SE 70) and 
adhesive resin film (SA 70) were sourced from Gurit, UK 
and also used as received. 
 
2.2. Methods 
 
2.2.1. Microencapsulation. Microcapsules containing epoxy 
resin and organic solvent were prepared by in situ 
polymerisation in an oil-in-water emulsion [21]. Briefly, 60 ml 
of water phase containing 1 wt% of emulsion stabiliser (EMA) 
was prepared in a round bottomed vessel and subsequently 1.25 
g of urea, 0.125 g of resorcinol and 0.125 g of ammonium 
chloride were added and dissolved. After that, the pH of the 
water phase was adjusted by dropwise addition of NaOH (≈0.2 
N) to 3.10. Stirring speed was increased to 800 rpm and 30 ml 
of measured oil phase was added dropwise. 3.16 g of formalin 
was added and the temperature was increased to 55 °C. After 4 
h, the stirrer was stopped, and the microcapsule slurry was left 
in the water medium for 24 h at ambient temperature. Next, 
microcapsules were filtered in order to separate capsules with 
desired size. Capsules were vacuum filtered and rinsed a few 
times with ethanol/water. The isolated capsules were post 
heated at 55 °C in an oven for 2 days. Yield of microcapsules 
was calculated relative to mass of used materials (Y%). 
 
 
2.2.2. Microcapsule analysis. Microcapsule diameter and size 
distribution was analysed by a Zeiss optical microscope AX10, 
Imager.M2 equipped with a video camera AxioCam. ICc 1. For 
the size distribution, image analysis software (ImageJ) was 
used. Mean diameter and size distribution were obtained from 
at least 500 measurements of capsule diameter. Surface 
morphology analysis for dry microcapsules was performed with 
a scanning electron microscope JOEL SEM 5600LV. Thermal 
stability of microcapsules was determined using 
thermogravimetric analysis (TGA). Mass loss of microcapsules 
was recorded during non-isotherm from 25 °C to 500 °C and 
isothermal measurements at using a TA Instruments Q500 
TGA. 
 
2.2.3. Composite manufacturing. Composites with embedded 
healing chemistries were manufactured using 
 
unidirectional carbon/epoxy resin tape (SE 70, Gurit UK) 
and adhesive resin film (SA 70, Gurit, UK) by standard 
hand-lay up technique (16 plies—160 mm × 195 mm). 
Laminates after lay-up were vacuum bagged on an 
aluminium tool plate and consolidated according to the 
manufacturer’s recommendations (at 100 °C for 100 min) 
under vacuum of 660–710 mmHg. The artificially created 
damage region was filled with a resin paste (SA70 resin film) 
containing healing chemistries at the desired weight loading 
(table 1). The filling paste was prepared by dispersion of dry 
capsules and/or catalyst at 65 °C. Each panel was equipped 
with a release film at 85 mm from the edge of specimens 
overlapping at minimum 500 μm of the resin pocket. The 
detailed configuration of the system is presented in the figure 
1. After curing, composite plates were removed from the 
vacuum bag and a 30 mm region from the panel front was 
grit blasted. Composite plates were then trimmed and cut 
into DCB specimens (20 mm × 175 mm). Piano hinges were 
bonded to the specimens at the pre-cracked end using 
Araldite 2014 structural adhesive and left at ambient 
temperature until fully cured. 
 
 
2.2.4. Types of specimens and geometry. The DCB tests 
specimens were used to quantify mode I recovery using manual 
and autonomous approaches to self-healing. The specimen 
geometry was adapted from the ASTM standard test method 
5528-01 [38].  
Two types of control specimens were manufactured and 
tested in order to determine a benchmark of the composite 
fracture properties and the effect of embedded SA 70 (Gurit, 
UK) resin interleaf. The Control 1 specimens, containing no 
additional interleaves, was used to determine the fracture 
properties of selected composite material (SE 70, Gurit, UK) 
and to determine a benchmark for mode I recovery using the 
resin formulation described in the literature [37]. Specimens 
were fractured according to the standard test method [38] and 
manually injected with liquid resin—catalyst formulation. After 
self-healing processes, the specimens were retested using the 
same approach. The Control 2 (figure 1) was used to determine 
the virgin fracture properties of the modified DCB geometry. 
This geometry was used in order to control the propagating 
crack from the non-bonding insert to the end of 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. CFRP double cantilever beam specimen (DCB) geometry adopted from ASTM standard test method 5528-01 [38], containing 
artificially created damage region with embedded self-healing chemistries. 
 
resin pocket through the embedded microcapsules and 
catalyst particles. Subsequently, the epoxy microcapsules 
and catalyst particles were embedded in the interleaf at 
various combinations. The crack introduced during mode I 
DCB testing ruptures microcapsules causing release of liquid 
monomer and subsequent contact with embedded particles of 
Sc(OTf)3. The detailed test specimen’s configurations are 
summarised in table 1. First, specimens containing literature 
loadings of microcapsules and the catalyst [9] were tested as 
the proof of concept for autonomic self-healing. The effect 
of microcapsules loading was determined at constant 
concentra-tion of the catalyst (2.5 wt%) and from 5.5 to 26 
wt% of microcapsules. The effect of Sc(OTf)3 particles was 
deter-mined later at constant loading of microcapsules (11 
wt%) and variable concentration of the catalyst ranging from 
1 to 10 wt%. It should be noted here that the weight fraction 
of the catalyst and microcapsules was measured relatively to 
the resin used as filler in the resin pocket. 
 
 
2.2.5. Mode I DCB fracture toughness (strain energy release 
rate) tests and healing quantification. An electromechanical 
test machine (Shimadzu AGX-X) equipped with 1 kN load cell 
and a video camera was used in opening mode I interlaminar 
fracture tests for virgin and healed DCB tests specimens. Tests 
were performed in accordance to the ASTM 5528-01 standard 
method [38]. Specimens were tested in crack opening mode at 3 
mm min
−1
 displacement rate, from the release film to the end of 
interleave resin region containing microcapsules. After testing, 
specimens were 
 
unloaded, sealed and left at 80 °C for 24 h. Healed 
specimens were retested using the same methodology. 
The healing efficiency (η) was calculated from the ratio 
of the healed maximum peak load (PHealed) to the virgin 
maximum peak load (PVirgin) 
h = 
PHealed  ⋅ 100%. 
 
P
Virgin 
 
Values of initial opening mode I interlaminar strain energy 
release rate (GIc) were determined for various specimens to 
demonstrate the effect of healing chemistries on the composite. 
The GIc values were calculated at the point of deviation from 
linearity on the load–displacement curves: 
3Pd 
GIc = ,  
 
where P is the applied load at the onset of nonlinearity, δ is 
the load point displacement, b and a are specimen average 
width and delamination length respectively. 
 
 
3. Results 
 
3.1. Microencapsulation 
 
Microcapsules containing the DGEBA were synthesised 
using in situ polymerisation in an oil-in-water emulsion [39]. 
Size distribution, corresponding scanning electron micro-
graphs and results for thermal stability are presented in 
figure 2. 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. (a) Size distribution of prepared poly(urea-formaldehyde) microcapsules containing 75 wt% of epoxy resin (EPON 828) and  
25 wt% of organic solvent (ethyl phenylacetate—EPA); (b) corresponding SEM image; (c) representative non-isothermal and (d) 
isothermal TGA traces for the microcapsules. 
 
Microcapsules after synthesis exhibited a wide size dis-
tribution ranging from 20 to 420 μm in diameter (figure 2(a)). 
The microencapsulation efficiency calculated according to the 
mass of used chemicals in the process resulted in satisfactory 
77%. Enclosed scanning electron micrograph (figure 2(b)) 
illustrate that the microcapsules have regular spherical shape 
and the shell wall is covered with rough polymeric layer of 
poly(urea-formaldehyde) [39]. The thermal stability of 
microcapsules was determined using TGA. The results of non-
isothermal analysis indicated that microcapsules are stable to 
170 °C (figure 2(c)). The first observed mass loss is associated 
with evaporation of ethyl phenylacetate (B.P. 229 °C) released 
from microcapsules. When poly(urea-for-maldehyde) 
decomposes, the organic solvent and epoxy resin are released 
and the organic solvent evaporates immediately. Increasing 
further temperature, a mass loss associated with the 
decomposition of DGEBA resin is observed. When the 
 
epoxy resin–organic solvent mixture is unprotected in poly-
meric shell, the increase of temperature and continues flow 
of purge gas (nitrogen), cause evaporation of the ethyl 
pheny-lacetate at much lower temperature. It is calculated 
that the solvent content in the healing resin is 25.4% and the 
epoxy resin is 74.6%. In addition, analysing figure 2(d) it is 
con-cluded that epoxy microcapsules are thermally stable 
when exposed to curing conditions of the selected carbon 
fibre/ epoxy resin pre-preg material (SE70 carbon/epoxy). A 
minor 2.5% mass loss calculated from the graph corresponds 
to water evaporation from the polymeric shell. 
 
3.2. Manual healing 
 
Blank DCB specimens were tested in order to determine a 
benchmark of mode I fracture toughness and self-healing 
using the resin formulation described in the literature as the 
most promising for such application [9, 36, 37]. After the 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Typical load–displacement curves for virgin and healed (a) control specimens type 1 containing no interleave resin and (b) 
specimens containing 26 wt% of microcapsules and 2.5 wt% solid phase catalyst in the interleave.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Fracture surfaces for control specimens type 1 (a) after initial fracture tests and (b) after manual repair and retest. 
 
Table 2. Summary of healing efficiency (η) and initial fracture toughness (GIC) in dependence on SH agent load/volume in the damage region.  
 
   Capsules Initial load Healed load  Initial  
 Designation Vol % size (μm) 
P
Virgin (
N
) 
P
Healed (
N
) η (%) GIC (J m
−2) Temp 
 Manual — — 47.0 ± 1.3 24.7 ± 4.3 52.5 ± 8.9 413 ± 19  
 Autonomous 26 20–450 57.2 ± 10.6 5.5 ± 1.5 9.9 ± 3.5 746 ± 97  
 Control 2 — — 81.0 ± 6.4 — — 1371 ± 224 80 °C 
 5.5 wt_2.5 wt% 5.5 250–420 71.0 ± 4.3 7.8 ± 2.0 10.7 ± 2.0 1076 ± 161  
 11 wt_2.5 wt% 11 250–420 77.0 ± 9.1 8.6 ± 1.8 11.3 ± 3.3 1311 ± 326  
 26 wt_2.5 wt% 26 250–420 68.4 ± 3.5 6.8 ± 1.7 11.8 ± 2.5 997 ± 86  
          
 
 
initial fracture tests, the DCB specimens were manually healed 
and retested using the same methodology. Healing was 
achieved by manual injection with the mixture containing 75 
wt% EPON 828—25 wt% ethyl phenylacetate and 3.25 phr of 
solid state scandium (III) triflate. A typical load displacement 
curve illustrating pristine fracture behaviour and crack arrest is 
presented in figure 3(a). The average healing efficiency 
calculated from the difference of maximum peak loads (Pmax) 
is 52.5%. This low value is associated with the 
 
 
lack of non-repairable fibre bridging developed in pristine 
specimens. Figure 4 illustrates fracture surfaces of DCB 
specimens after the initial tests and after the manual repair. 
A cohesive debonding mode of injected and polymerised 
epoxy resin is observed which suggests that the strength of 
the interface between carbon fibres and the epoxy resin is 
higher than fracture strength of the resin. Detailed data for 
healing efficiency (η) and initial interlaminar fracture 
toughness (GIC) are summarised in table 2. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Artificially created resin-pocket in representative DCB specimens (a) before and (b) after the initial mode I fracture toughness test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. SEM image of DCB fracture surfaces of a specimen 
containing resin pocket and no microcapsules and catalyst dispersed in 
the damage region.  
 
chemistries caused substantial decrease in initial maximum 
load (Pmax) at crack onset and corresponding GIC values 
(table 2). It indicates that microcapsules and catalyst have a 
detrimental effect on the proposed FRP composite. Figure 6 
shows a representative fracture surface for Control 2 speci-
men revealing no features of crack arrest in the SA 70 epoxy 
resin. Surface morphology for autonomous specimens (figure 
7) illustrates ruptured microcapsules, catalyst particles and 
thin film created by polymerised epoxy healing agent 
covering the fracture surface. The excessive porosity created 
by liquid filled microcapsules was assumed to be responsible 
for such high decrease in materials virgin properties. Further 
work focused on optimisation of microcapsules size and 
catalyst load with the aim of increasing the self-healing rate 
and examining the effect of healing components on material 
performance. 
 
The data collected here indicate that the resin formulation 
described in the literature [36, 37] is capable of successful 
restoration of mode I properties of the selected epoxy resin/ 
carbon fibre material (SE70, Gurit, UK). In liquid phase, the 
healing agent has a low viscosity and long gel time allowing 
penetration and wetting of the fractured surfaces. In the 
solidified state, the epoxy resin is plasticised by the organic 
solvent (EPA) what results in increased fracture toughness that 
in non-modified resin. Such modification results in steady and 
progressive crack propagation for the manually healed DCB 
specimens as presented in figure 3(a). 
 
3.3. Autonomous self-healing 
 
Autonomous self-healing was determined for a series of 
specimens containing microcapsules and catalyst in the 
interleave region (figure 5). First, tests were performed for 
maximum load of microcapsules (26 wt%) and load of cata-lyst 
adapted from literature (2.5 wt%) [9]. Figure 3(b) repre-sents a 
typical load–displacement curve for virgin and healed DCB 
specimens. The observed crack arrest indicates that the 
chemistries embedded in the interleave region are active after 
composite manufacturing and polymerised healing agent bonds 
the fractured surfaces. However, the average self-healing 
efficiency is not exceeded 10% of the value of maximum load at 
the crack onset. Embedded healing 
 
3.3.1. The effect of microcapsules load. Self-healing was 
determined for specimens containing variable concentrations of 
microcapsules dispersed in the composite interleave (table 1). It 
was assumed that the low healing efficiency is associated with 
low bonding area in the proof of the concept study (see entry 
‘autonomous’ in table 2). Loading of microcapsules was 
calculated according to the mass of SA 70 resin used in the 
manufacturing of each separate panel and corresponds to 5.5, 11 
and 26 wt%. Here, the diameter of microcapsules was limited to 
250–420 μm in order to ensure their full rupture by a 
propagating crack and to decrease the induced porosity. 
Fracture morphology illustrating microcapsule distribution in 
the damage zone is presented in figure 8. Table 2 summarises 
results, which indicate that recovery of mode I is independent of 
microcapsule loading. Moreover, an average 12% self-healing 
was observed for all test specimens. It indicates that volume of 
encapsulated liquid monomer is enough to cover the fracture 
surface and bridge them after polymerisation. It was assumed 
that the low self-healing rate is a result of low crosslinking 
density in the newly formed epoxy resin. Increasing the number 
of polymerisation centres could result in tougher polymer that 
should bond the fractured surfaces more effectively. 
Additionally, a minimum decrease in initial fracture toughness 
(GIC) was observed between specimens without microcapsules 
(Control 2) and containing 11 wt% of microcapsules (250–420 
μm). Reducing the number of 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. (a) Fracture morphology of a specimen containing 25 wt% microcapsules dispersed in polymeric matrix and 2.5 wt% of catalyst 
particles, (b) image illustrating ruptured microcapsules at higher magnification and (c) image illustrating undissolved catalyst particles covered in 
thin film of epoxy healing agent.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. SEM images of surface morphologies for DCB specimens containing variable loading of microcapsules embedded in the interleave 
region; (a) 5.5 wt%, (b) 11 wt% and (c) 26 wt%; at constant load of catalyst (2.5 wt%).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. (a) Self-healing efficiency and (b) initial fracture toughness (GIC) for specimens containing variable volume of self-healing phase using 
microcapsules within 250–450 μm range. 
 
microcapsules in the damage zone, an increase of the maximum 
peak load (Pmax) and calculated fracture toughness (GIC) is 
observed (table 2). Reducing the number of the stress 
concentration regions, a 16 N increase of Pmax and 251 J m
−2
 
of GIC is calculated bringing the value close to Control 2 
specimen. These facts suggest that the size and size distribution 
of microcapsules can be tailored in FRP composites to deliver 
healing functionality with minimum detrimental effect. In 
further work, DCB specimens were prepared at this 
microcapsules concentration, the work aimed 
 
to increase the self-healing rate by manipulating the catalyst 
concentration in the system. 
 
3.3.2. The effect of Sc(OTf)3 concentration. To increase the 
self-healing rate and to understand the effect of catalyst 
particles on initial fracture properties, a series of specimens 
containing variable loadings of Sc(OTf)3 at constant 
concentration of microcapsules (11 wt%) were prepared and 
tested. Specimens were healed for 48 h in order to ensure full 
crosslinking of released healing agent. Table 3 summarises 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. (a) Self-healing efficiency and (b) initial fracture toughness (GIC) for specimens containing variable weight of Sc(OTf)3 at 11 wt% 
microcapsules (250–450 μm range).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Fracture morphologies of DCB samples containing 11 wt% of capsules and (a) 1 wt% catalyst, (b) 5 wt% catalyst and 10 wt% catalyst. 
 
 
Table 3. Summary of healing efficiency (η) and fracture toughness (GIC) in dependence on Sc(OTf)3 load dispersed in the interleave region.   
   Capsules Initial load Healed load  Initial Healing 
 Designation Vol % size (μm) 
P
Virgin (
N
) 
P
Healed (
N
) η (%) GIC (J m
−2) temp 
 Control 2 — — 81.0 ± 6.4 — — 1371 ± 224  
 11 wt_0.0 wt% 10 250–420 83.1 ± 5.3 13.2 ± 1.3 14.2 ± 5.7 1399 ± 186  
 11 wt_1.0 wt% 10 250–420 73.4 ± 9.5 12.7 ± 3.2 17.7 ± 6.1 1184 ± 158 80 °C 
 11 wt_5.0 wt% 10 250–420 59.4 ± 6.9 14.0 ± 0.5 23.8 ± 3.5 777 ± 170  
 11 wt_10 wt% 10 250–420 38.4 ± 7.8 15.8 ± 2.0 43.6 ± 15.0 301 ± 99  
          
 
the test results where figure 10 presents a series of results 
collected for the specimens containing 0, 1, 5 and 10 wt% of 
Sc(OTf)3. The maximum 44% of self-healing was obtained at 
maximum catalyst loading (10 wt%) and decreases with lower 
load of the catalyst. In addition, an average of 14% recovery 
was obtained for specimens containing no catalyst particles, 
indicating the presence of solvent promoted self-healing [15]. It 
is concluded that the increase of healing rate is associated with 
a substantial decrease in initial fracture properties. Results in 
table 3 suggest that the initial fracture toughness (GIC) 
decreased to 301 J m
−2
, which is close to that observed for 
Control 1 specimens containing no resin interleave— 413 J m−2 
(table 2). The values of the maximum peak load (Pmax) for all 
healed specimens remains in the same range 
 
(13.2–16.0 N) indicating that the presence of catalyst has no 
beneficial effect on the mode I recovery. Figure 11 illustrates 
altered fracture surfaces containing 1, 5 and 10 wt% of the 
catalyst particles. The fracture morphology containing only 
microcapsules is illustrated in figure 12. 
 
 
 
4. Discussion 
 
An autonomous self-healing based on epoxy resin filled 
microcapsules and solid phase catalyst is demonstrated in a 
high performance CFRP composite (cured at 100 °C for 100 
min) and examined for its performance. The crack arrests 
observed on the load–displacement curves (figure 2) indicate 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. SEM image of DCB specimen containing 11 wt% of 
microcapsules (250–450 μm range) in the damage region.  
 
 
that the released epoxy resin undergoes polymerisation after 
contact with dispersed catalyst particles and bonds the frac-ture 
surfaces. The SEM analysis (figure 7) revealed ruptured 
microcapsules, residual catalyst particles and thin film of epoxy 
healing agent covering the fracture surfaces. It was found that 
mode I recovery is dependent on the catalyst loading and 
reached 44% maximum (comparable to 52% for manually 
healed). However, this increase is associated with substantial 
(3×) decrease in initial fracture toughness (GIC) and the 
maximum load at the crack onset (Pmax). Never-theless, it is 
demonstrated that concentration of microcapsules embedded in 
the damage region can be tailored to achieve self-healing with 
minimal detrimental effect on the structure. Moreover, reducing 
the number of microcapsules by remov-ing the samples with 
size smaller than 250 μm, an increase in maximum peak load 
(Pmax) and fracture toughness (GIC) is observed. It suggest that 
the wide range of microcapsules’ diameter generates excessive 
porosity that impedes the properties of the host material. Low 
healing efficiency was associated with low cross-linking rate 
initiated by the chosen catalytic curing agent (Sc(OTf)3) and its 
presence as a solid. Attempts to increase the self-healing rate by 
tailoring the catalyst loading resulted in further decrease of the 
composite fracture properties without any gain of mode I 
recovery.  
While the concentration of microcapsules has no effect on 
self-healing efficiency (table 2), their higher concentration 
caused a decrease in the host material’s initial fracture 
toughness and change in fracture morphology. This trend was 
already observed in epoxy based polymers [9, 10, 22], adhesives 
[40] and woven composites [5, 12, 19, 23], where inclusion of 
microcapsules always gave rise to a decrease in material 
attributes. Microcapsules and catalyst particles are considered 
as voids, creating discontinuities in the host polymer and acting 
as stress concentrations. To minimise the effect, microcapsule 
diameter was restricted to 250–420 μm which resulted in 
average GIC close to virgin at 11 wt% of microcapsules (figure 
9). In addition, inclusion of the inter-leave region filled with 
capsules resulted in a 3× increase in G1c when compared to 
blank specimens (table 2). It is asso-ciated with the presence of 
bulk epoxy resin at the crack 
 
initiation point. In blank specimens the crack is initiated at 
the weak interface between the carbon fibre and the 
polymeric matrix. In the developed structure, the crack is 
initiated in a bulk epoxy resin (SA 70) that exhibited much 
higher fracture toughness than the strength of the interface.  
To increase the self-healing efficiency, a series of spe-
cimens containing higher concentrations of solid phase cata-lyst 
were prepared and tested. While the healing efficiency increased 
with catalyst concentration, a substantial reduction in initial 
fracture toughness was recorded (figure 10). The maximum 
healing efficiency (44%) reached values for control specimens 
repaired by manual injection (52%). Similarly, observed 
reduction of fracture properties is associated with excessive 
presence of voids created by scandium (III) triflate particles in 
the fracture planes. It is illustrated in figures 11(b) and (c) where 
microcapsules are surrounded by Sc(OTf)3 particles that 
significantly alter the fracture morphology. In general, 
undissolved catalyst particles, their detrimental effect on 
material attributes, and little beneficial effect on healing rate, 
suggest that application of a microcapsule—solid phase catalyst 
system in high performance FRP composite struc-tures is 
questionable.  
In summary, an autonomous self-healing is demonstrated 
and assessed for its performance in a unidirectional FRP 
composite structure. The work shows that microcapsule healing 
can be adapted and optimised in unidirectional FRP composite 
materials. However, the investigated system, which relies on a 
distribution of microcapsules and a solid phase catalyst, is 
detrimental to the FRP composite. Inter-laminar fracture 
toughness (GIC) is severely affected by pre-sence of both 
healing components. The low solubility of scandium (III) triflate 
in liquid resin, it is premature con-sumption, the detrimental 
effect on the host structure and little beneficial effect on healing 
efficiency were identified as substantial limitations for 
commercialisation. Therefore, an alternative system based on a 
single component healing sys-tem or integrated double capsules 
should be considered for such an application. A microcapsule—
catalyst system could be considered as an adhesive, where 
inhibited reactivity is required for extended period of time. 
Nevertheless, it has been demonstrated that microcapsule self-
healing can be achieved in a unidirectional FRP composite 
cured at high temperature (100 °C) and located in regions of 
possible damages. 
 
 
 
5. Conclusions 
 
An autonomous self-healing system was demonstrated in a high 
performance unidirectional FRP composite using epoxy resin 
filled microcapsules and a solid phase catalyst (Sc (OTf)3). 
Healing efficiency and effect of microcapsules on the structure 
was assessed using mode I fracture toughness test-ing. A 
maximum of 52% and 44% recovery was obtained for 
specimens healed manually and autonomously, respectively. 
However, inclusion of resin interleaves and healing chemis-tries 
in laminates have a detrimental effect on their perfor-mance. It 
has been demonstrated that amount of both healing 
 
 
  
 
components can be tailored to avoid a decrease in material 
performance.  
Furthermore, the application of a solid phase catalyst 
remained questionable due to its low efficiency in the poly-
merisation of encapsulated epoxy healing agent. A similar 
crack arrest rate after healing was obtained for specimens 
containing only microcapsules (12%). Nevertheless, autono-
mous self-healing was achieved in a structural component 
based on commercial epoxy resin/carbon fibre tape (SE70 
Carbon, Gurit, UK). It is also demonstrated that the healing 
chemistry can be located in regions of possible damage in 
composite components. 
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